Inventor

PERLMAN ANDREW J

US14 patents

⚠️ This page may combine multiple inventors who share the name “PERLMAN ANDREW J”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

MENLO THERAPEUTICS INC

10 patents

US10278952B2May 7, 2019

Use of NK-1 receptor antagonists in pruritus

MENLO THERAPEUTICS INC3 citations83

US10278953B2May 7, 2019

Use of NK-1 receptor antagonist serlopitant in pruritus

MENLO THERAPEUTICS INC3 citations83

US9974769B2May 22, 2018

Use of NK-1 receptor antagonist serlopitant in pruritus

MENLO THERAPEUTICS INC5 citations83

US9968588B2May 15, 2018

Use of NK-1 receptor antagonists in pruritus

MENLO THERAPEUTICS INC5 citations83

US9737507B2Aug 22, 2017

Use of NK-1 receptor antagonist serlopitant in pruritus

MENLO THERAPEUTICS INC8 citations83

US9737508B2Aug 22, 2017

Use of NK-1 receptor antagonists in pruritus

MENLO THERAPEUTICS INC7 citations83

US9486439B2Nov 8, 2016

Use of NK-1 receptor antagonist serlopitant in pruritus

MENLO THERAPEUTICS INC7 citations83

US9474741B2Oct 25, 2016

Use of NK-1 receptor antagonists in pruritus

MENLO THERAPEUTICS INC7 citations83

US10702499B2Jul 7, 2020

Use of NK-1 receptor antagonists in pruritus

MENLO THERAPEUTICS INC1 citations72

US10617671B2Apr 14, 2020

Use of NK-1 receptor antagonist serlopitant in pruritus

MENLO THERAPEUTICS INC1 citations72

TIGERCAT PHARMA INC

3 patents

US9381188B2Jul 5, 2016

Use of NK-1 receptor antagonists in pruritus

TIGERCAT PHARMA INC9 citations91

US9198898B2Dec 1, 2015

Use of NK-1 receptor antagonists in pruritus

TIGERCAT PHARMA INC20 citations91

US8906951B1Dec 9, 2014

Use of NK-1 receptor antagonists in pruritus

TIGERCAT PHARMA INC15 citations91

VYNE THERAPEUTICS INC

1 patent

US11026920B2Jun 8, 2021

Use of NK-1 receptor antagonist serlopitant in pruritus

VYNE THERAPEUTICS INC0 citations60